Bill Text: IL HB3517 | 2015-2016 | 99th General Assembly | Introduced

---

Bill Title: Amends the Pharmacy Practice Act. Provides that beginning July 1, 2015, every new or refilled prescription for a Schedule II controlled substance shall only be dispensed in a medicine locking closure package. Defines "medicine locking closure package" and "Schedule II controlled substance". Provides that the medicine locking closure package may not be reusable. Provides that the medicine locking closure package must be dispensed by the pharmacy with instructions for patient use. Provides that the manufacturer of the medicine locking closure package must make assistance available online or through a toll-free number for patients. Effective immediately.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2015-04-24 - Rule 19(a) / Re-referred to Rules Committee [HB3517 Detail]

Download: Illinois-2015-HB3517-Introduced.html

---

99TH GENERAL ASSEMBLY State of Illinois 2015 and 2016 HB3517 Introduced , by Rep. Robert F. Martwick SYNOPSIS AS INTRODUCED:
225 ILCS 85/16c new
Amends the Pharmacy Practice Act. Provides that beginning July 1, 2015, every new or refilled prescription for a Schedule II controlled substance shall only be dispensed in a medicine locking closure package. Defines "medicine locking closure package" and "Schedule II controlled substance". Provides that the medicine locking closure package may not be reusable. Provides that the medicine locking closure package must be dispensed by the pharmacy with instructions for patient use. Provides that the manufacturer of the medicine locking closure package must make assistance available online or through a toll-free number for patients. Effective immediately.
LRB099 10752 HAF 31047 b
A BILL FOR
HB3517 LRB099 10752 HAF 31047 b
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Pharmacy Practice Act is amended by adding
Section 16c as follows:
(225 ILCS 85/16c new)
Sec. 16c. Medicine locking closure package.
(a) As used in this Section:
"Medicine locking closure package" means any alphanumeric
combination locking closure mechanism that can only be unlocked
with a user-generated, resettable alphanumeric code in
combination with an amber prescription container that forms a
package that allows only the person with the prescription in
the package access to the medicine.
"Schedule II controlled substance" means a Schedule II
controlled substance under the United States Controlled
Substances Act and 21 CFR 1308.
(b) Beginning July 1, 2015, every new or refilled
prescription for a Schedule II controlled substance shall only
be dispensed in a medicine locking closure package. The
medicine locking closure package may not be reusable. The
medicine locking closure package must be dispensed by the
pharmacy with instructions for patient use. The manufacturer of

HB3517 - 2 - LRB099 10752 HAF 31047 b
the medicine locking closure package must make available
assistance online or through a toll-free number for patient
use.
Section 99. Effective date. This Act takes effect upon
becoming law.